Literature DB >> 698045

Lodgement and extravasation of tumour cells in blood-borne metastasis: an electron microscope study.

M Kinjo.   

Abstract

Soon after i.v. injection of ascites hepatoma cells of rat, 3 types of tumour-cell emboli were found in arterioles and capillaries of the lung. The first type had marked aggregation of platelets and deposition of fibrin. Many were seen when tumour cells with high thromboplastic activity (AH 130) were injected, and were often followed by detachment and fragmentation of endothelial cells. The second type had loosely aggregated platelets and the third type had no aggregation of platelets or deposition of fibrin. The latter 2 types were mainly seen when the tumour cells with low thromboplastic activity [AH 130 F(N)] were injected, and they did not accompany severe structural changes of the endothelial cells. Tumour cell-platelet complexes appeared to be induced by tissue thromboplastin released from tumour cells rather than from the endothelial cells. One to 6 h after injection of AH 130, tumour cells were found beneath the endothelial cells detached from the basement membrane in areas with microthrombi. Breaching of the endothelial cells with the processes of tumour cells was also seen then. Intrusion of the processes of tumour cells into the endothelial cells was noted in groups injected with either AH 130 or AH 130 F(N), but not in the junctions of the endothelial cells. Metastatic foci 3 days after the injection of AH 130 were more frequent than in the rats injected with AH 130 F(N). These results indicate that thromboplastic activity of tumour cells might be important in forming microthrombi in the lodgement phase and might be one of the factors facilitating blood-borne metastasis.

Entities:  

Mesh:

Year:  1978        PMID: 698045      PMCID: PMC2009708          DOI: 10.1038/bjc.1978.201

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  [DEVELOPMENT OF FREE-CELL SUBLINES OF THE ASCITES HEPATOMA AH-130 AND THEIR BIOLOGICAL PROPERTIES].

Authors:  I HIRONO; K KOJIMA; H KACHI; A OHASHI; I SASAOKA
Journal:  Gan       Date:  1964-10

2.  Electron micrographic observations on the emigration of leucocytes.

Authors:  V T MARCHESI; H W FLOREY
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1960-10

3.  Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber.

Authors:  S WOOD
Journal:  AMA Arch Pathol       Date:  1958-10

4.  Electron microscopic observations on formation of pulmonary metastases.

Authors:  W F Sindelar; T S Tralka; A S Ketcham
Journal:  J Surg Res       Date:  1975-02       Impact factor: 2.192

5.  [Experimental transformation of DAB-hepatoma of rats into the ascites form].

Authors:  T ARUJI
Journal:  Gan       Date:  1953-09

Review 6.  Environment of the blood-borne tumor embolus adherent to vessel wall.

Authors:  B A Warren
Journal:  J Med       Date:  1973

7.  An electron microscopic study of pulmonary tumor emboli from transplantable Morris hepatoma 5123.

Authors:  R M Ludatscher; S A Luse; V Suntzeff
Journal:  Cancer Res       Date:  1967-11       Impact factor: 12.701

8.  Enhancement of experimental metastasis by x-ray: a possible mechanism.

Authors:  I J Fidler; I Zeidman
Journal:  J Med       Date:  1972

9.  Pulmonary metastasis formation after intravenous tumour cell injection in defibrinogenated rats.

Authors:  L Ivarsson
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-01-02

10.  Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.

Authors:  G J Gasic; T B Gasic; N Galanti; T Johnson; S Murphy
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

View more
  22 in total

1.  Organ-specificity of the extravasation process: an ultrastructural study.

Authors:  S Paku; B Döme; R Tóth; J Timár
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  Radiation enhancement of metastasis: a review.

Authors:  C F von Essen
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

3.  Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells.

Authors:  Nawal Bendris; Carrie J S Stearns; Carlos R Reis; Jaime Rodriguez-Canales; Hui Liu; Agnieszka W Witkiewicz; Sandra L Schmid
Journal:  J Cell Sci       Date:  2016-06-08       Impact factor: 5.285

4.  Endothelialization of embolized tumor cells during metastasis formation.

Authors:  K Lapis; S Paku; L A Liotta
Journal:  Clin Exp Metastasis       Date:  1988 Jan-Feb       Impact factor: 5.150

Review 5.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

Review 6.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

Review 7.  Analysis of the lodgement and extravasation of tumor cells in experimental models of hematogenous metastasis.

Authors:  T Kawaguchi; K Nakamura
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

8.  Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.

Authors:  H S Chiang; M W Swaim; T F Huang
Journal:  Breast Cancer Res Treat       Date:  1995-03       Impact factor: 4.872

9.  Establishment of a human renal pelvic cancer cell line producing tissue thromboplastin and plasminogen activator.

Authors:  S Naito; K Tanaka; T Kanamori; S Hisano; S Momose
Journal:  Urol Res       Date:  1982-02

10.  Platelet fibronectin release induced by Walker 256 rat carcinoma tumor cells.

Authors:  W A Turner; D C Szlag; J D Taylor
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.